Wanbury Q2 FY25 revenue at Rs. 161.2 crore, up 11.6% - Indian Pharma Post
2024-11-16 • Google News
Wanbury Limited (WANBURY)
NSEINR 234.863.82%
Price Chart
Key Statistics
Market Cap
INR 7.33B
P/E Ratio
17.11
Revenue (TTM)
INR 5.67B
Volume
101.05K
52W High
INR 323.53
52W Low
INR 131.20
Dividend Yield
0.00%
Beta
0.80
Technicals
50-Day MA
215.847
200-Day MA
224.7132
52 Week High
323.53
52 Week Low
131.2
About WANBURY
Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for gynecology, orthopedics, hematinic, an.
Employees
1491
Headquarters
Navi Mumbai, India
CEO
Mr. Mohan Kumar Rayana
Latest News
Wanbury Limited Announces Financial Results and Strategic Initiatives - TipRanks
2025-02-12 • Google News
Benign Growth For Wanbury Limited (NSE:WANBURY) Underpins Stock's 28% Plummet - Simply Wall St
2025-02-04 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg